TY - JOUR
AU - Narang I
AU - Ailawadi P
AU - Garg V
AB - The efficacy of thalidomide has been a landmark in the treatment of ENL, especially the severe forms like ENL necroticans. Thalidomide does have its share of adverse effects (AE), but with the low doses used in leprosy, we do not encounter very severe AEs, seen with its use in myeloid malignancies and other illnesses. We describe here a case of ENL treated with thalidomide and subsequent development of some seldom reported severe AE like pancytopenia and severe neuropsychriatric symptoms. Such features of drug toxicity must be taken into consideration while monitoring a patient of ENL on thalidomide.
BT - Leprosy review
DO - 10.47276/lr.91.2.200
IS - 2
LA - eng
N2 - The efficacy of thalidomide has been a landmark in the treatment of ENL, especially the severe forms like ENL necroticans. Thalidomide does have its share of adverse effects (AE), but with the low doses used in leprosy, we do not encounter very severe AEs, seen with its use in myeloid malignancies and other illnesses. We describe here a case of ENL treated with thalidomide and subsequent development of some seldom reported severe AE like pancytopenia and severe neuropsychriatric symptoms. Such features of drug toxicity must be taken into consideration while monitoring a patient of ENL on thalidomide.
PB - Lepra
PY - 2020
SP - 200
EP - 203
T2 - Leprosy review
TI - Uncommon adverse effects of thalidomide: seldom reported phenomena in leprosy
UR - https://leprosyreview.org/article/91/2/19-0080
VL - 91
SN - 2162-8807
ER -